METLIFE INC Insider Trading Activity
MORRISON DENISE M reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MORRISON DENISE M reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc. director Denise M. Morrison received a grant of 721 shares of MetLife common stock on 2026-04-01 as part of non-management director compensation arrangements. The shares were awarded at $0.00 per share, reflecting stock-based fees rather than a market purchase.
After this award, Morrison directly holds 34,711 shares of MetLife common stock. A portion of MetLife’s non-management director retainer fees is paid in common stock, so this transaction represents routine equity compensation rather than an open-market trade.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 721 | $0.00 | $0.00 |
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
Key Figures
Key Terms
non-management director compensation arrangements financial
common stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MetLife (MET) director Denise Morrison report in this Form 4?
Was the MetLife (MET) Form 4 transaction an open-market purchase or sale?
Why did MetLife (MET) grant common stock to its non-management director?
Does the MetLife (MET) Form 4 indicate any derivative or option exercises?
AI-generated analysis. How Rhea-AI works. Not financial advice.